Tag: Novo Nordisk

Driven by a rebound in large and megacap stocks, in particular the “Magnificent Seven” technology companies, mutual-fund managers who saw ...

U.S. cities racing to cut their emissions are facing a roadblock: They can’t access the wind and solar power being ...

Some of this year’s best performers in the healthcare sector are companies expected to profit from the anti-obesity drug craze, ...

Oct. 23, 2023 11:39 am ETThe company behind diabetes and obesity phenomena Ozempic and Wegovy is overweight.Novo Nordisk became Europe’s ...

Long-term Treasury yields continued to ease.

Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...

What to Read Next

MarketsHeard on the StreetThe decision to get into the business for drugs such as Ozempic makes sense